SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Exelixis, Inc. (EXEL)
An SI Board Since January 2001
Posts SubjectMarks Bans Symbol
930 66 0 EXEL
Emcee:  kinkblot Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
455Just parking the detailed PR. Exelixis Initiates Phase 3 Trial of XL184 in MedLJM-7/21/2008
4546:07AM On The Wires (WIRES) : Exelixis (EXEL) announces that the Ph. 3 registratIan@SI-7/21/2008
453Thanks Eric. JonRobohogs-6/29/2008
452<i>This is a very easy way to check if there has been any new SEC-filings DewDiligence_on_SI-6/29/2008
451Just put a bookmark for each of the pages you would like to check (such as sec.gIcebrg-6/29/2008
450What is the tabbed search approach? JonRobohogs-6/29/2008
449Thank you, Erik.tom pope-6/29/2008
448It depends on what you understand with keyword news aggregators. I am using GoIcebrg-6/29/2008
447<i> Do any folks use keyword news aggregators and if so which ones?</i&tom pope-6/28/2008
446My broker sends me news items for any stock that I select. Looking at Yahoo, itIan@SI-6/28/2008
445It was on YHOO headlines - who is your provider? Jon PS Do any folks use keywRobohogs-6/28/2008
444I didn't get this PR thru my provider. Did any one else get it? ++++++++++Ian@SI-6/27/2008
443Exelixis has obtained an SPA from FDA on XL184 phase III trial for medullary thyidos-6/16/2008
442Exelixis Presents Clinical Data Supporting the Safety and Initial Clinical ActivLJM-6/13/2008
441No one will buy them with their current burn rate. This is the scorched earth burkrw-6/5/2008
440Perhaps they will once some more pipeline visibility creates adequate value. NeIan@SI-6/5/2008
439Warrants, commitment fees, interest, more warrants, more fees, more warrants… whDewDiligence_on_SI-6/5/2008
438Exelixis Receives $150 Million Funding Commitment From Deerfield Management Thurkenhott-6/5/2008
437Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO Jun 2, 2008 09:00:0LJM-6/2/2008
436Appears they are at least partly looking at the INCY drug in making this decisiokenhott-5/16/2008
435cc transcript: seekingalpha.commopgcw-5/14/2008
434I own a lot less exel now. Whether ceo is perfectly honest with shareholders iskeokalani'nui-5/7/2008
433INCY did talk of the significant neurotoxicity of EXEL's compound, per softwtuck-5/7/2008
432Not too surprising from exel. Here's what they said in December, hadn'rkrw-5/7/2008
431Anyone else here surprised to learn that x019 may be a little too hot (neuropathkeokalani'nui-5/7/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News